Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance

References

• JoyceHMcCannAClynesMLarkinAInfluence of multidrug resistance and drug transport proteins on chemotherapy drug metabolismExpert Opin Drug Metab Toxicol201511579580925836015
   PubMed Web of Science ®Google Scholar
• KathawalaRJGuptaPAshbyCRJrChenZSThe modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decadeDrug Resist Updat20151811725554624
   PubMed Web of Science ®Google Scholar
• MerkJRolffJDornCLeschberGFichtnerIChemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?Eur J Cardiothorac Surg2011401e29e3321420313
   PubMed Web of Science ®Google Scholar
• SelleFWittnebelSBironPA phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II studyAnn Oncol20142591775178224894084
   PubMed Web of Science ®Google Scholar
• TirmazySHBarthakurUEl-ModirAAnwarSFernandoIChemotherapy for advanced endometrial cancer with carboplatin and epirubicinAnticancer Res20143473793379824982404
   PubMed Web of Science ®Google Scholar
• RattiFCiprianiFCatenaMPaganelliMAldrighettiLLiver failure in patients treated with chemotherapy for colorectal liver metastases: role of chronic disease scores in patients undergoing major liver surgery. A case-matched analysisEur J Surg Oncol201440111550155625085794
   PubMed Web of Science ®Google Scholar
• BeusterienKGrinspanJKuchukIUse of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effectsOncologist201419212713424473225
   PubMed Web of Science ®Google Scholar
• KunickáTSoučekPImportance of ABCC1 for cancer therapy and prognosisDrug Metab Rev201446332534224670052
   PubMed Web of Science ®Google Scholar
• WuCPHsiehCHWuYSThe emergence of drug transporter-mediated multidrug resistance to cancer chemotherapyMol Pharm201181996201121770407
   PubMed Web of Science ®Google Scholar
• AzzaritiAPorcelliLQuatraleAESilvestrisNParadisoAThe coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapyCurr Drug Metab20111271372121434858
   PubMed Web of Science ®Google Scholar
• ChenYTangYGuoCWangJBoralDNieDNuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transportersBiochem Pharmacol2012831112112622326308
   PubMed Web of Science ®Google Scholar
• SinghNSarkarJSashidharaKVAliSSinhaSAnti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratioApoptosis20141961017102824638227
   PubMed Web of Science ®Google Scholar
• KontosCKChristodoulouMIScorilasAApoptosis-related BCL2-family members: key players in chemotherapyAnticancer Agents Med Chem201414335337423848200
   PubMed Web of Science ®Google Scholar
• KlukovitsAKrajcsiPMechanisms and therapeutic potential of inhibiting drug efflux transportersExpert Opin Drug Metab Toxicol201511690792025802976
   PubMed Web of Science ®Google Scholar
• NatarajanKXieYBaerMRRossDDRole of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceBiochem Pharmacol2012831084110322248732
   PubMed Web of Science ®Google Scholar
• KovalevAATsvetaevaDAGrudinskajaTVRole of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancerExp Oncol201335428729024382439
   PubMedGoogle Scholar
• YangJJMiltonMNYuSP-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitorDrug Metab Lett20104420121220670210
   PubMedGoogle Scholar
• FerreiraRJdos SantosDJFerreiraMJP-glycoprotein and membrane roles in multidrug resistanceFuture Med Chem20157792994626061109
   PubMed Web of Science ®Google Scholar
• SeebacherNARichardsonDRJanssonPJGlucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeuticsBr J Pharmacol2015172102557257225586174
   PubMed Web of Science ®Google Scholar
• BinkhathlanZLavasanifarAP-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectivesCurr Cancer Drug Targets201313332634623369096
   PubMed Web of Science ®Google Scholar
• XuePYangXLiuYXiongCRuanJA novel compound RY10-4 downregulates P-glycoprotein expression and reverses multidrug-resistant phenotype in human breast cancer MCF-7/ADR cellsBiomed Pharmacother20146881049105625455158
   PubMed Web of Science ®Google Scholar
• SantosSAPauloASmall molecule inhibitors of multidrug resistance gene (MDR1) expression: preclinical evaluation and mechanisms of actionCurr Cancer Drug Targets201313881482823876050
   PubMed Web of Science ®Google Scholar
• KueteVEfferthTAfrican flora has the potential to fight multidrug resistance of cancerBiomed Res Int2015201591481325961047
   PubMed Web of Science ®Google Scholar
• NobiliSLandiniIGiglioniBMiniEPharmacological strategies for overcoming multidrug resistanceCurr Drug Targets20067786187916842217
   PubMed Web of Science ®Google Scholar
• WirthTParkerNYlä-HerttualaSHistory of gene therapyGene2013525216216923618815
   PubMed Web of Science ®Google Scholar
• KaufmannKBBüningHGalyASchambachAGrezMGene therapy on the moveEMBO Mol Med20135111642166124106209
   PubMed Web of Science ®Google Scholar
• WangFLiTZhangBMicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTENBiochem Biophys Res Commun2013434368869423603256
   PubMed Web of Science ®Google Scholar
• LiJMZhangWSuHReversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrierInt J Nanomedicine2015103147316225960653
   PubMed Web of Science ®Google Scholar
• Martinez-QuintanillaJCascalloMGrosAFillatCAlemanyRPositive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapyMol Cancer Ther20098113098310719887556
   PubMed Web of Science ®Google Scholar
• WuZLiXZengYIn vitro and in vivo inhibition of MRP gene expression and reversal of multidrug resistance by siRNABasic Clin Pharmacol Toxicol2011108317718421073659
   PubMed Web of Science ®Google Scholar
• LiMDengHPengHWangQFunctional nanoparticles in targeting glioma diagnosis and therapiesJ Nanosci Nanotechnol201414141543224730272
   PubMed Web of Science ®Google Scholar
• IkobaUPengHLiHMillerCYuCWangQNanocarriers in therapy of infectious and inflammatory diseasesNanoscale20157104291430525680099
   PubMed Web of Science ®Google Scholar
• XuHLiZSiJNanocarriers in gene therapy: a reviewJ Biomed Nanotechnol201410123483350726000367
   PubMed Web of Science ®Google Scholar
• YangYWangSWangYWangXWangQChenMAdvances in self-assembled chitosan nanomaterials for drug deliveryBiotechnol Adv20143271301131625109677
   PubMed Web of Science ®Google Scholar
• DingFDengHDuYShiXWangQEmerging chitin and chitosan nanofibrous materials for biomedical applicationsNanoscale20146169477949325000536
   PubMed Web of Science ®Google Scholar
• SongFLiXWangQLiaoLZhangCNanocomposite hydrogels and their applications in drug delivery and tissue engineeringJ Biomed Nanotechnol2015111405226301299
   PubMed Web of Science ®Google Scholar
• LiMHYuHWangTFTamoxifen embedded in lipid bilayer improves the oncotarget of liposomal daunorubicin in vivoJ Mater Chem B Mater Biol Med201421216191625
   PubMed Web of Science ®Google Scholar
• ShenHSunTFerrariMNanovector delivery of siRNA for cancer therapyCancer Gene Ther201219636737322555511
   PubMed Web of Science ®Google Scholar
• BatesKKostarelosKCarbon nanotubes as vectors for gene therapy: past achievements, present challenges and future goalsAdv Drug Deliv Rev201365152023203324184373
   PubMed Web of Science ®Google Scholar
• HuFQChenWWZhaoMDYuanHDuYZEffective antitumor gene therapy delivered by polyethylenimine-conjugated stearic acid-g-chitosan oligosaccharide micellesGene Ther201320659760622951455
   PubMed Web of Science ®Google Scholar
• RafteryRO’BrienFJCryanSAChitosan for gene delivery and orthopedic tissue engineering applicationsMolecules20131855611564723676471
   PubMed Web of Science ®Google Scholar
• SuCLiHShiYCarboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acidInt J Pharm20144741–220221125149123
   PubMedGoogle Scholar
• LiuMFengBShiYSuCSongHChengWZhaoLProtamine nanoparticles for improving shRNA-mediated anti-cancer effectsNanoscale Res Lett20151013425852425
   PubMed Web of Science ®Google Scholar
• ZhaoLSuRCuiWShiYLiuLSuCPreparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediationInt J Nanomedicine201492149215624851048
   PubMed Web of Science ®Google Scholar